Lutein
Lutein
TL;DR
Lutein with zeaxanthin at 10 mg and 2 mg is the AREDS2 formulation, the dose with the strongest evidence for slowing progression of age-related macular degeneration in people who already have intermediate disease. It also raises macular pigment density and shows small benefits for glare recovery and screen-related visual fatigue.
Ideal For
- People with intermediate age-related macular degeneration, where AREDS2 evidence applies
- Those with a family history of AMD
- Heavy screen users reporting visual fatigue and glare sensitivity
- Adults with low dietary intake of leafy greens and egg yolks
- Smokers and former smokers who should avoid beta-carotene formulations
Avoid If
- You expect it to reverse existing macular damage
- You have early-stage or no AMD and expect the AREDS2 benefit to apply
- You are taking it without any dietary fat
- You are pregnant, where supplemental doses lack data — dietary intake is fine
Frequently Asked Questions
Overview
Lutein and zeaxanthin are xanthophyll carotenoids that the body cannot make and that are selectively concentrated in one place: the macula, where they form the yellow macular pigment. That accumulation is not incidental. The pigment absorbs high-energy blue light before it reaches the photoreceptors and quenches the singlet oxygen and peroxyl radicals generated in a tissue with the highest oxygen consumption per gram in the body.
The best evidence comes from AREDS2, a large NIH trial in people with intermediate age-related macular degeneration. Substituting 10 mg lutein and 2 mg zeaxanthin for beta-carotene in the original AREDS formula produced a modest further reduction in progression to advanced AMD, and critically removed the increased lung cancer risk beta-carotene carried in current and former smokers. The benefit was clearest in participants with the lowest dietary lutein intake at baseline. Importantly, AREDS2 did not show benefit in people with early or no AMD — this is a formulation for established intermediate disease, not a general eye vitamin.
Beyond AMD, supplementation reliably raises macular pigment optical density over three to six months, and trials in young adults with heavy screen exposure show small improvements in contrast sensitivity, glare recovery time and self-reported eye fatigue. Evidence for cataract prevention is observational and weak. There is preliminary work on cognition, where macular pigment density correlates with processing speed.
Practically, lutein is fat-soluble and needs to be taken with a fat-containing meal; absorption from supplements exceeds that from raw vegetables considerably. Meso-zeaxanthin, present in some products, is formed in the retina from lutein and its supplemental value is debated. Benign skin yellowing at very high intakes is the only common adverse effect.
How It Works
- Selectively accumulates in the macula to form the protective macular pigment
- Absorbs high-energy blue light before it reaches photoreceptors
- Quenches singlet oxygen and peroxyl radicals in a highly oxygen-exposed tissue
- Improves contrast sensitivity and shortens photostress recovery time
- Reduces lipofuscin accumulation in retinal pigment epithelium in preclinical models
- Crosses into brain tissue, where levels correlate with cognitive processing speed
Quick Facts
- Concentrates in the macula of the eye
- Filters harmful blue light
- Reduces macular degeneration risk
- Improves visual performance
- Synergistic with zeaxanthin
Benefits & Outcomes
Eye Health Support
Lutein with zeaxanthin has the strongest supplement evidence in eye health, mainly for slowing advanced macular degeneration progression.
Antioxidant Protection
Lutein is a well-characterised carotenoid antioxidant that concentrates in the retina and reliably raises macular pigment.
Health Concerns Addressed
Macular Degeneration
Supported by the AREDS2 randomised trial as part of the formula for intermediate or advanced AMD.
Eye Strain
Lutein is well supported for macular health but only weakly studied for digital eye strain. A few small trials suggest modest improvement in visual fatigue symptoms; the 20-20-20 rule and a correct prescription do more.
Cataracts
AREDS tested antioxidant prevention and found no cataract benefit; no trial supports lutein for cataracts.
Vision Changes
Worth taking if you already have intermediate age-related macular degeneration, as part of the AREDS2 formulation. Not a way to sharpen normal vision.
Supporting Research20 studies
Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults
Renzi-Hammond LM, Bovier ER, Fletcher LM
One year of lutein and zeaxanthin improved macular pigment and some measures of processing speed in young healthy adults.
Effects of lutein/zeaxanthin supplementation on the cognitive function of community dwelling older adults: a randomized, double-masked, placebo-controlled trial
Hammond BR, Miller LS, Bello MO +3 more
Supplemented participants showed improved complex attention and cognitive flexibility relative to placebo, with gains correlated to increases in macular pigment optical density.
Macular Pigment and Percentage of Body Fat
Nolan JM, Loskutova E, Howard AN +11 more
Macular pigment optical density was inversely related to percentage body fat, consistent with sequestration of lutein and zeaxanthin in adipose tissue reducing retinal availability. Supplementation raised macular pigment even in participants with higher body fat, though response varied.
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4
Chew EY, SanGiovanni JP, Ferris FL +2 more
Participants were randomly assigned to daily placebo; lutein/zeaxanthin, 10mg/2mg; omega-3 long-chain polyunsaturated fatty acids, 1 g; or a combination.
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3
AREDS2 Research Group, Chew EY, Clemons TE
In participants with the lowest dietary intake, lutein/zeaxanthin supplementation reduced progression to advanced age-related macular degeneration.
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
Antioxidant vitamin and mineral supplements slowed progression to late age-related macular degeneration.
Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration
Liu R, Wang T, Zhang B
Lutein supplementation improved macular pigment optical density and contrast sensitivity.
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
Age-Related Eye Disease Study 2 Research Group, Chew EY, Clemons TE +8 more
Addition of lutein and zeaxanthin to the AREDS formulation did not further reduce risk of progression to advanced AMD overall.
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
Lutein plus zeaxanthin was a suitable substitute for beta-carotene in the AREDS formulation without added overall benefit for progression.
Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration: a meta-analysis
Liu R, Wang T, Zhang B
Lutein and zeaxanthin increased macular pigment optical density in a dose-response manner and modestly improved visual acuity in AMD.
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28
Substituting lutein/zeaxanthin for beta-carotene reduced progression to late AMD over ten years.
Effect of supplementation with lutein, zeaxanthin, and omega-3 fatty acids on macular pigment and visual function in young adults with long-term use of digital devices: study protocol for a randomized double-blind placebo-controlled study
Wang L, Ma M, Li Y +3 more
Current trial evidence on lutein bioavailability is contradictory
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
Oral antioxidant and lutein/zeaxanthin supplements slowed geographic atrophy progression toward the fovea.
Lutein and zeaxanthin for the prevention of age-related cataract
Mathew MC, Ervin AM, Tao J +1 more
There is no evidence from randomised trials that antioxidant or carotenoid supplementation prevents or slows age-related cataract.
Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial
Chew EY, Clemons TE, Agron E
Lutein/zeaxanthin supplementation had no significant effect on cognitive decline over five years.
Effects of lutein supplementation on visual fatigue and macular pigment in screen users: a randomized controlled trial
Ma L, Lin XM, Zou ZY
Lutein 12 mg/day for 12 weeks improved contrast sensitivity in long-term computer users.
Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial
Power R, Nolan JM, Prado-Cabrero A +1 more
Following 24-month supplementation, individuals in the active group recorded significantly fewer errors in working memory tasks than individuals receiving placebo.
The effect of lutein on eye and extra-eye health
Buscemi S, Corleo D, Di Pace F +3 more
Lutein accumulates in the macula and skin and has documented roles beyond ocular tissue.
Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis
Ma L, Dou HL, Wu YQ +5 more
Higher dietary lutein and zeaxanthin intake was associated with a 26% lower risk of late age-related macular degeneration.
Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration
Liu R, Wang T, Zhang B +4 more
Lutein and zeaxanthin supplementation increased macular pigment optical density and improved visual acuity and contrast sensitivity in AMD.
Safety Information
Potential Side Effects
Extremely safe with no significant side effects. May cause mild yellowing of skin (carotenodermia) at very high doses - harmless and reversible. Typical dose 10-20mg daily. Often combined with zeaxanthin 2-4mg. Take with fat for absorption.
Contraindications
No significant contraindications at dietary or standard supplemental doses. Carotenodermia — harmless skin yellowing — occurs at very high chronic intakes.
Drug Interactions
- Orlistat and bile acid sequestrants — reduced carotenoid absorption
- Beta-carotene supplements — compete for the same absorption pathway
- Statins — may modestly alter carotenoid transport in lipoproteins
Pregnancy & Breastfeeding
Pregnancy: insufficient_data
Breastfeeding: likely_safe
Dosage Guidelines
Dosage Used in Studies
10-20 mg
Best Time to Take
Once daily with the largest fat-containing meal
Best Form
Lutein 10 mg with zeaxanthin 2 mg, taken with a fat-containing meal
Bioavailability
Lutein requires dietary fat and bile for micellar incorporation; taking it with fat can increase absorption several-fold. Supplemental lutein is absorbed considerably better than lutein from raw vegetables, and cooking with fat improves dietary uptake.
Forms Compared
Lutein with zeaxanthin 10:2
Marigold-derived lutein esters
Free (non-esterified) lutein
With meso-zeaxanthin
Full AREDS2 formula
Food & Timing
With a meal containing fat — absorption is poor from a fat-free meal
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.